时间 | 指标 | 对照组 | 观察组 | P值 |
治疗前 | ALT (U/L) | 15.73 ± 4.61 | 16.58 ± 5.80 | 0.447 |
AST (U/L) | 18.33 ± 4.35 | 18.82 ± 5.59 | 0.645 | |
BUN (μmol/L) | 34.64 ± 7.92 | 32.26 ± 7.91 | 0.157 | |
Scr (μmol/L) | 769.39 (636.50, 841.15) | 717.57 (559.60, 810.85) | 0.217 | |
eGFR (ml/min/1.73m2) | 9.11 ± 1.88 | 9.93 ± 2.31 | 0.069 | |
治疗后 | ALT (U/L) | 16.87 ± 3.22 | 16.96 ± 3.84 | 0.906 |
AST (U/L) | 18.80 ± 3.74 | 18.53 ± 3.95 | 0.743 | |
BUN (μmol/L) | 33.22 ± 5.06 | 32.05 ± 5.64 | 0.304 | |
Scr (μmol/L) | 740.69 (653.00, 817.00) | 705.99 (612.00, 772.00) | 0.202 | |
eGFR (ml/min/1.73m2) | 9.33 ± 1.94 | 9.85 ± 2.01 | 0.212 |